Stocks and Investing Stocks and Investing
Wed, July 13, 2022

Joshua Jennings Maintained (ABT) at Buy with Decreased Target to $130 on, Jul 13th, 2022


Published on 2024-10-27 21:52:51 - WOPRAI, Joshua Jennings
  Print publication without navigation


Joshua Jennings of TD Cowen, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $150 to $130 on, Jul 13th, 2022.

Joshua has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 1 agrees with Joshua's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold and Held Target at $140 on, Thursday, April 21st, 2022


These are the ratings of the 9 analyists that currently disagree with Joshua


  • Mike Polark of "Wolfe Research" Initiated at Sell on, Wednesday, July 6th, 2022
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Decreased Target to $116 on, Tuesday, July 5th, 2022
  • Marie Thibault of "BTIG" Maintained at Strong Buy with Decreased Target to $130 on, Friday, June 24th, 2022
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $145 on, Tuesday, June 7th, 2022
  • Travis Steed of "B of A Securities" Maintained at Strong Buy and Held Target at $140 on, Tuesday, May 31st, 2022
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 17th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $135 on, Thursday, April 21st, 2022
  • Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $143 on, Thursday, April 21st, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022
Contributing Sources